Investigators in this section are involved in technological advancement of testing and diagnosis as well as the pathological basis of disease. Meghan Delaney, D.O., M.P.H., is an international leader in pediatric transfusion medicine who focuses on decreasing risks of transfusion and investigating the best approach to transfusion of patients who have, or are at risk for, alloimmunization as well as the use of antifibrinolytics to decrease bleeding. As a continued interest, she focuses on transfusion improvement and medical education in developing nations by leading courses and sustainable technology development in developing nations. She also serves as the chair of the AABB’s the Transfusion Medicine Subsection Pediatric Subcommittee for AABB and the American Society of Apheresis Applications Committee Pediatric Subcommittee. She is an Associate Editor for the journal Transfusion Medicine, and on the editorial board of Transfusion. She is an Associate Scientific Member of the BEST Collaborative, an international research and science consortium focused on safer transfusion.  

Our Team